Mizuho Slashes Circle Price Target to $50, Downgrades to Underperform on Open USD Threat
Mizuho slashed Circle to Underperform with a $50 price target, warning that Open USD's yield-pass-through model threatens Circle's margins by shifting reserve…
Mizuho slashed Circle to Underperform with a $50 price target, warning that Open USD's yield-pass-through model threatens Circle's margins by shifting reserve…
Wikipedia blackout risks hollowing AI crypto comprehension, threatening market sentiment and price stability as reliance on outdated coverage guidelines persists.
Regulatory alignment between the U.S. and UK on tokenized assets promises to cut compliance costs and lift crypto markets over the mid-term.
CleanSpark (CLSK) shares rallied 22% after the company disclosed a $6.6 billion lease deal for a Georgia data center, a move that…
A small batch of Nvidia AI chips reached China under a U.S. license, highlighting narrow exemptions to export curbs.
BoE Governor Bailey warns AI bubble burst would trigger immediate rate response, signaling proactive stance against tech-driven financial risks and setting up…
London's IPO market revival faces another setback, with a meaningful recovery not expected before 2027, as weak investor appetite and global competition…
Anchorage Digital now offers institutional TRX staking directly from custody, giving clients yield exposure to Tron’s USDT-heavy settlement network without off-platform transfers.
India's Udaan secures $160 million in fresh funding to fortify its balance sheet before a planned initial public offering, reflecting robust investor…
Bitcoin’s OP_CSFS and OP_CAT opcodes allow scripts to enforce spending conditions and verify transaction layouts, advancing trust-minimized covenants natively.
JPMorgan analysts caution that Hyperliquid's strategic deal with Circle and Coinbase forms a prisoner's dilemma, threatening the earnings structure of USDC and…
Biogen's stock tumbled as its tau-directed Alzheimer's candidate disappointed in clinical testing, stoking concerns over the drugmaker's pipeline durability and potentially reshaping…